Poland· PL-100326589
Valcyte
A valganciclovir product containing valganciclovirum, registered in Poland by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Valganciclovir is registered in 18 of 19 countries.
Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Valganciclovir · ATC J05AB14
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valganciclovir costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Valganciclovir · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- IT Italy$35.27
- CH Switzerland$35.18
- FR France$22.39
- US United States$3.83 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Valganciclovirum
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH
- Country
- Poland (PL)
- ATC code
- J05AB14
- ATC class
- Valganciclovir
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05902768001082
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for valganciclovir.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valganciclovir · interactions on record
283 records
- 8 severe
- 193 moderate
- 82 info
Most severe, free to view
- CladribineL01BB04severe
- TrospiumA03AB20moderate
- Amphotericin BA07AA07moderate
- TrospiumG04BD09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valganciclovir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesValcyteH2-Pharma, LLC
- FinlandValcyteParanova Oy
- SpainVALCYTE 50 mg/ml POLVO PARA SOLUCION ORALCheplapharm Arzneimittel Gmbh
- FranceROVALCYTE 50 mg/ml, poudre pour solution buvableCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- BelgiumValcyte 50 mg/mlCheplapharm Arzneimittel
- IcelandValcyteCHEPLAPHARM Arzneimittel GmbH
- NetherlandsValcyte 50 mg/ml, poeder voor drankCheplapharm Arzneimittel GmbH
- NorwayValcyteCheplapharm Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Valcyte, Valganciclovir +pharma
- Belgium · Valcyte, Valganciclovir Sandoz
- Bulgaria · Алваноцит, Валцит
- Cyprus · Valcyte, Valganciclovir Accord
- Czechia · Cytevix, Valcyte
- Germany · Valcyte, Valganaxiro
- Denmark · Valcyte, Valganciclovir "medical Valley"
- Estonia · Valganciclovir Accord, Valganciclovir Sandoz
- Spain · Valcyte, Valganciclovir Accord
- Finland · Valcyte, Valganciclovir Accord
- France · Rovalcyte, Valganciclovir Accord
- United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
- Greece · Vagotrosin, Valcyte
- Croatia · Alvanocyt, Valcyte
- Hungary · Valcyte, Valdamin
- Ireland · Valcyte, Valganciclovir Accord Healthcare
- Iceland · Valcyte, Valganciclovir Medical Valley
- Italy · Valcyte, Valganciclovir Accord
- Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
- Luxembourg · Valcyte
- Latvia · Valcyte, Valganciclovir Accord
- Netherlands · Alvanocyt, Valcyte
- Norway · Valcyte, Valganciclovir Accord
- Portugal · Rovalcyte, Valganciclovir Accord
- Romania · Valganciclovir Zentiva
- Sweden · Valcyte, Valganciclovir Accord
- Slovenia · Ganaxa, Valcyte
- Slovakia · Valdamin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af1558e5-0fb8-4ebd-8c6f-08b5e8b31f18 GET /v1/drugs/af1558e5-0fb8-4ebd-8c6f-08b5e8b31f18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu doustnego",
"source": "urpl",
"strength": "50 mg/ml",
"packaging": "05902768001082 ¦ Rp ¦ 104301\n1 butelka 12 g",
"substance": "Valganciclovirum 5 g",
"common_name": "Valganciclovirum",
"pl_product_id": "100326589",
"pozwolenie_nr": "22066",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about valganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.